/CIMVF

CIMVF Stock - Pideka Group Inc.

Q: What is the analyst price target for CIMVF?

Analyst price target information is not currently available for CIMVF.

Q: What is CIMVF's market cap?

Market capitalization information is not currently available for CIMVF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.01+0.00%

+$0.00 (+0.00%) • May 4

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CIMVF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.57

52W High$0.01

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2020	FY2019
Revenue	$4,099.378	$113.343
Gross Profit	$535.986	$-2.986
Gross Margin	13.1%	-2.6%
Operating Income	$-91,030	$-271,190
Net Income	$-91,028	$-271,190
Net Margin	-2220.5%	-239264.9%
EPS	$-0.01	$-0.03

Company Overview

Ikänik Farms, Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator in California and Colombia. The company offers pharmaceutical grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil for scientific and commercial sales. It provides its products under the Ikanik, Essentials, Ronen, and Rations brands. The company is headquartered in Toronto, Canada.

Visit Website

Earnings History & Surprises

CIMVF

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.01

Q3 2021

EPS Surprise History

Q1 20

No data

Q2 20

No data

Q3 20

No data

Q2 21

No data

Q2 21

No data

Q3 21

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2021	Sep 30, 2021	—	$-0.01	—	—
Q2 2021	Jun 30, 2021	—	$-0.06	—	—
Q2 2021	Jun 1, 2021	—	$-0.02	—	—
Q3 2020	Sep 30, 2020	—	$-0.04	—	—
Q2 2020	Jun 30, 2020	—	$-0.03	—	—
Q1 2020	Mar 31, 2020	—	$-0.05	—	—

Frequently Asked Questions about CIMVF

What is CIMVF's current stock price?

Pideka Group Inc. (CIMVF) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for CIMVF?

No analyst price targets are currently available for this stock.

What sector is Pideka Group Inc. in?

Pideka Group Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CIMVF's market cap?

Pideka Group Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does CIMVF pay dividends?

No, Pideka Group Inc. does not currently pay a dividend to shareholders.